On this week’s episode of “The Readout LOUD,” we bring you a special conversation with Stelios Papadopolous, also know as the “godfather” of biotech. He sat down for an on-stage chat with our colleague Damian Garde Thursday afternoon during STAT’s Breakthrough Summit East event in New York City.
We also chat about the latest biotech news, including new weight loss data from Structure Therapeutics and Eli Lilly, plus recent staff departures from the Food and Drug Administration.
To read more on Structure’s readout, go here; to learn more about Eli Lilly’s latest data, go here; for more on the FDA staff departures, go here; to read more on Johnson & Johnson’s newly approved psoriasis pill, go here; and for an in-depth profile on Papadopolous, go here.
Be sure to sign up for “The Readout LOUD” on Apple Podcasts, Spotify, or wherever you get your podcasts.
Correction: The new data from Structure was on its GLP-1 drug, not amylin drug.
